My understanding from last announcement by company is that they will be doing everything to get it HDE approval that will give them fastest route to US market.
Obviously UK team is gearing up and they are hiring people who worked in marketing & sales of similar / oncology / radiology related devices particularly Andy and Rachel as per my post above to increase private partnership/awareness among private paying patients through doctors... IMO.
I can see based on past history it has been sleeping dog stock... ! but it will get life IMO moving forward with new management (CEO) team. I am not expecting anything from this quarter update but before December if we get TGA approval and submission to FDA for HDE by Aug/Sept 2021 then 2022 will In My Opinion (IMO) rerate the stock price.
GLAH.
Article Supporting Oncosil Trial, page-22
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $31.31M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.7¢ | $19.71K | 2.475M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 25681033 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 5068750 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |